Ozempic Copies at $14 in India as Generic GLP-1 Era Starts (1)

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the third-largest overweight population.

Natco Pharma Ltd. plans to make an injection for semaglutide — the active ingredient in both Ozempic and Wegovy — that will have a starting price of 1,290 rupees ($14) a month, on the first day the generics are allowed. The pen device is expected to launch by April and cost about 4,500 rupees a month, it said in a filing.

By ...